Metabotropic glutamate receptors: potential drug targets for psychiatric disorders
- PMID: 21160908
- PMCID: PMC3002053
- DOI: 10.2174/1874104501004020020
Metabotropic glutamate receptors: potential drug targets for psychiatric disorders
Abstract
Metabotropic glutamate receptors (mGlu receptors) have emerged as new therapeutic targets for psychiatric disorders, such as schizophrenia, depression and anxiety with their regulatory roles in glutamatergic transmissions. To date, several ligands selective for each mGlu receptor have been synthesized, and pharmacological significances of these ligands have been demonstrated in animal models. Among them, mGlu2/3 receptor agonists have been proven to be effective for treating schizophrenia and anxiety disorders in clinical studies, which may prove utilities of mGlu receptor ligands for the treatment of psychiatric disorders. This article reviews recent advances in development of each mGlu receptor ligands and their therapeutic potential.
Keywords: Metabotropic glutamate receptor; drug target.; mGlu; psychiatric disorder.
Figures








Similar articles
-
Targeting of metabotropic glutamate receptors for the treatment of schizophrenia.Curr Pharm Des. 2011;17(2):94-102. doi: 10.2174/138161211795049570. Curr Pharm Des. 2011. PMID: 21355835 Review.
-
Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.Neuropharmacology. 2013 Mar;66:264-73. doi: 10.1016/j.neuropharm.2012.05.023. Epub 2012 May 30. Neuropharmacology. 2013. PMID: 22659090
-
The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?Eur J Pharmacol. 2014 Jan 15;723:181-4. doi: 10.1016/j.ejphar.2013.12.019. Epub 2013 Dec 18. Eur J Pharmacol. 2014. PMID: 24361306 Review.
-
Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.Eur J Pharmacol. 2010 Aug 10;639(1-3):59-66. doi: 10.1016/j.ejphar.2009.12.041. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371240 Review.
-
Glutamate metabotropic receptors as targets for drug therapy in epilepsy.Eur J Pharmacol. 2003 Aug 22;476(1-2):3-16. doi: 10.1016/s0014-2999(03)02149-6. Eur J Pharmacol. 2003. PMID: 12969743 Review.
Cited by
-
Valproic Acid Influences MTNR1A Intracellular Trafficking and Signaling in a β-Arrestin 2-Dependent Manner.Mol Neurobiol. 2016 Mar;53(2):1237-1246. doi: 10.1007/s12035-014-9085-y. Epub 2015 Jan 24. Mol Neurobiol. 2016. PMID: 25613019
-
The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review.Molecules. 2024 Apr 23;29(9):1930. doi: 10.3390/molecules29091930. Molecules. 2024. PMID: 38731421 Free PMC article. Review.
-
Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.Int J Mol Sci. 2020 Nov 20;21(22):8811. doi: 10.3390/ijms21228811. Int J Mol Sci. 2020. PMID: 33233865 Free PMC article. Review.
-
Quinoline derivatives: candidate drugs for a class B G-protein coupled receptor, the calcitonin gene-related peptide receptor, a cause of migraines.CNS Neurol Disord Drug Targets. 2014;13(7):1130-9. doi: 10.2174/1871527313666140917111341. CNS Neurol Disord Drug Targets. 2014. PMID: 25230231 Free PMC article.
-
Results and evaluation of a first-in-human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods.Br J Clin Pharmacol. 2018 Mar;84(3):445-455. doi: 10.1111/bcp.13466. Epub 2017 Dec 18. Br J Clin Pharmacol. 2018. PMID: 29096426 Free PMC article. Clinical Trial.
References
-
- Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 1992;258:597–603. - PubMed
-
- Nakanishi S, Masu M. Molecular diversity and functions of glutamate receptors. Ann. Rev. Biophys. Biomol. Struct. 1994;23:319–348. - PubMed
-
- Pin J P, Duvoisin R. The metabotropic glutamate receptors: structure and fuctions. J. Neurochem. 1992;58:1184–1186. - PubMed
-
- Schoepp D D, Conn P J. Metabotropic glutamate receptors in brain function and pathology. Trend Pharmacol. Sci. 1993;14:13–20. - PubMed
-
- Conn P J, Pin J P. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 1997;37:205–237. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources